Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2007; Volume 189, Supplement 653
The 86th Annual Meeting of The German Physiological Society
3/25/2007-3/28/2007
Hannover, Germany


B2 INTEGRIN (CD11B/CD18)-MEDIATED SIGNALING VIA THE TYROSINE KINASE SYK AND HIP-55 IS CRITICAL FOR PHAGOCYTOSIS OF IC3B-OPSONIZED BACTERIA
Abstract number: P26-L7-11

Gerstl1 R, Mocsai1 A, Schymeinsky1 J, Walzog1 B

1Physiologisches Institut, Ludwig-Maximilans-Universitt, Mnchen

Innate host defence depends on efficient phagocytosis that is mainly mediated by polymorphonuclear neutrophils (PMN). Phagocytosis is facilitated upon opsonization of bacteria by the complement factor iC3b which is recognized by the b2 integrin CD11b/CD18. Here, we studied the functional impact of CD11b/CD18-mediated signaling for phagocytosis of iC3b- opsonized E. coli. By means of confocal microscopy, we found that binding iC3b-opsonized E. coli to CD11b/CD18 induced the formation of a signalosome consisting of the tyrosine kinase Syk, the actin binding protein Hip-55, and the large GTPase dynamin. This effect was abolished upon pharmacological inhibition of Syk using piceatannol (30 mM). Pharmacological inhibition of Syk or downregulation of Syk by shRNA technique significantly inhibited phagocytosis of iC3b-opsonized E. coli to 41.6%± 2.5 % and 24.8%± 18.7 (p < 0.005) when compared to phagocytosis of untreated control cells (100%). Similar results were obtained using murine Syk deficient PMN, where phagocytosis was reduced to 31.2 ± 18.5 (p < 0.005). In addition, downregulation of Hip-55 by shRNA significantly impaired phagocytosis to 46.4%± 26.5% (p < 0.005). In conclusion, our data indicate that signaling via Syk and Hip-55 is required for efficient phagocytosis of iC3b- opsonized bacteria. (Supported by DFG WA 1048/2-3).

To cite this abstract, please use the following information:
Acta Physiologica 2007; Volume 189, Supplement 653 :P26-L7-11

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE